Correspondence to “Intracranial Pressure Monitoring and Unfavorable Outcomes”

Abstract

We would like to express our surprise after reading the reply to Dr. Chiara Robba's Intracranial pressure monitoring and unfavorable outcomes correspondence, written by Brazilian physicians Welling et al., in which the possibilities and tools available for intracranial pressure monitoring in both national and international scenarios are described, stating that “intracranial pressure monitoring is not included in the management strategy for neurocritical patients”, using BEST TRIP[1] as such reference. Our astonishment lies in the fact that we, authors of this letter, use intracranial pressure (ICP) monitoring as a daily practice in our neurocritical care unit. As representatives of The Neurocritical Care Committee of the Brazilian Association of Intensive Care Medicine (AMIB, in the Portuguese acronym), we recommend monitoring intracranial pressure in neurocritical patients, since monitoring-guided treatment of intracranial hypertension is associated with a potential improvement in treatment outcomes.